Bvf Inc Immunic, Inc. Transaction History
Bvf Inc
- $2.28 Billion
- Q1 2025
A detailed history of Bvf Inc transactions in Immunic, Inc. stock. As of the latest transaction made, Bvf Inc holds 8,902,972 shares of IMUX stock, worth $6.32 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
8,902,972
Previous 8,902,972
-0.0%
Holding current value
$6.32 Million
Previous $8.9 Million
9.01%
% of portfolio
0.43%
Previous 0.33%
Shares
2 transactions
Others Institutions Holding IMUX
# of Institutions
75Shares Held
40.2MCall Options Held
1.14MPut Options Held
130K-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$5.18 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$3.16 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.93MShares$2.79 Million0.0% of portfolio
-
Gratus Capital LLC2.11MShares$1.5 Million0.1% of portfolio
-
Omega Fund Management, LLC Boston, MA1.79MShares$1.27 Million4.02% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $21.7M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...